Cas no 227318-75-4 (1H-Imidazo[4,5-c][1,5]naphthyridin-4-amine,2-methyl-1-(2-methylpropyl)-)
1H-Imidazo[4,5-c][1,5]naphthyridin-4-amine,2-methyl-1-(2-methylpropyl)- Chemical and Physical Properties
Names and Identifiers
-
- 1H-Imidazo[4,5-c][1,5]naphthyridin-4-amine,2-methyl-1-(2-methylpropyl)-
- 2-methyl-1-(2-methylpropyl)imidazo[4,5-c][1,5]naphthyridin-4-amine
- AC1O52EI
- CHEMBL2107373
- R 850
- R-850
- S-30594
- Sotirimod
- Sotirimod (USAN)
- Sotirimod [USAN]
- SureCN191424
- UNII-X04FQM7J4M
-
- Inchi: 1S/C14H17N5/c1-8(2)7-19-9(3)17-12-13(19)11-10(18-14(12)15)5-4-6-16-11/h4-6,8H,7H2,1-3H3,(H2,15,18)
- InChI Key: ZXBCLVSLRUWISJ-UHFFFAOYSA-N
- SMILES: N1(C(C)=NC2C(N)=NC3=CC=CN=C3C1=2)CC(C)C
Computed Properties
- Exact Mass: 255.14861
Experimental Properties
- PSA: 69.62
1H-Imidazo[4,5-c][1,5]naphthyridin-4-amine,2-methyl-1-(2-methylpropyl)- Security Information
- Storage Condition:Please store the product under the recommended conditions in the Certificate of Analysis.
1H-Imidazo[4,5-c][1,5]naphthyridin-4-amine,2-methyl-1-(2-methylpropyl)- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | S880192-1mg |
Sotirimod |
227318-75-4 | 98% | 1mg |
¥12,882.00 | 2022-01-13 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | S880192-5mg |
Sotirimod |
227318-75-4 | 98% | 5mg |
¥25,764.00 | 2022-01-13 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajce45168-1mg |
Sotirimod (R850) |
227318-75-4 | 98% | 1mg |
¥10074.00 | 2023-09-08 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajce45168-5mg |
Sotirimod (R850) |
227318-75-4 | 98% | 5mg |
¥20150.00 | 2023-09-08 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajce45168-10mg |
Sotirimod (R850) |
227318-75-4 | 98% | 10mg |
¥34861.00 | 2023-09-08 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajce45168-20mg |
Sotirimod (R850) |
227318-75-4 | 98% | 20mg |
¥61164.00 | 2023-09-08 | |
| Biosynth | CJA31875-1 mg |
Sotirimod |
227318-75-4 | 1mg |
$1,952.50 | 2023-01-05 | ||
| Ambeed | A1176470-5mg |
1-Isobutyl-2-methyl-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine |
227318-75-4 | 99+% | 5mg |
$3077.0 | 2025-02-21 | |
| MedChemExpress | HY-101589-10mM*1 mL in DMSO |
Sotirimod |
227318-75-4 | 99.90% | 10mM*1 mL in DMSO |
¥7021 | 2024-07-24 | |
| MedChemExpress | HY-101589-1mg |
Sotirimod |
227318-75-4 | 99.90% | 1mg |
¥2500 | 2024-07-24 |
1H-Imidazo[4,5-c][1,5]naphthyridin-4-amine,2-methyl-1-(2-methylpropyl)- Related Literature
-
Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
-
Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
-
Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
-
Jason Wan Lab Chip, 2020,20, 4528-4538
-
Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
Additional information on 1H-Imidazo[4,5-c][1,5]naphthyridin-4-amine,2-methyl-1-(2-methylpropyl)-
Comprehensive Overview of 1H-Imidazo[4,5-c][1,5]naphthyridin-4-amine, 2-methyl-1-(2-methylpropyl)- (CAS No. 227318-75-4)
The compound 1H-Imidazo[4,5-c][1,5]naphthyridin-4-amine, 2-methyl-1-(2-methylpropyl)- (CAS No. 227318-75-4) is a heterocyclic organic molecule that has garnered significant attention in pharmaceutical and biochemical research due to its unique structural properties. This compound belongs to the class of imidazo-naphthyridine derivatives, which are known for their potential applications in drug discovery and development. Researchers are particularly interested in its molecular interactions and bioactivity, as it may serve as a key intermediate or active ingredient in therapeutic agents targeting various diseases.
In recent years, the demand for specialty chemicals like 1H-Imidazo[4,5-c][1,5]naphthyridin-4-amine has surged, driven by advancements in precision medicine and biotechnology. The compound's structural complexity and functional versatility make it a subject of interest in high-throughput screening and computational chemistry. Its CAS No. 227318-75-4 is frequently searched in academic and industrial databases, reflecting its relevance in contemporary scientific inquiries.
One of the most discussed topics in relation to this compound is its potential role in kinase inhibition. Kinases are enzymes that play a critical role in cellular signaling pathways, and their dysregulation is associated with numerous diseases, including cancer and inflammatory disorders. The imidazo-naphthyridine core of this compound is structurally similar to known kinase inhibitors, prompting investigations into its pharmacological properties. Researchers are exploring its binding affinity and selectivity to determine its suitability as a therapeutic candidate.
Another area of interest is the compound's synthetic accessibility. The development of efficient and scalable synthetic routes for 1H-Imidazo[4,5-c][1,5]naphthyridin-4-amine is a key focus for chemists. Optimizing its synthesis not only reduces production costs but also ensures consistent quality for research and potential commercial applications. Recent publications have highlighted innovative catalytic methods and green chemistry approaches to produce this compound with higher yields and lower environmental impact.
The compound's physicochemical properties, such as solubility, stability, and lipophilicity, are also critical for its application in drug formulation. These properties influence its bioavailability and metabolic stability, which are essential factors in preclinical development. Analytical techniques like HPLC, NMR, and mass spectrometry are routinely employed to characterize and quantify 1H-Imidazo[4,5-c][1,5]naphthyridin-4-amine in various matrices.
From a commercial perspective, the global market for fine chemicals and pharmaceutical intermediates is expanding, with 1H-Imidazo[4,5-c][1,5]naphthyridin-4-amine being a notable example. Suppliers and manufacturers are increasingly listing this compound in their catalogs to meet the growing demand from academic institutions, contract research organizations (CROs), and pharmaceutical companies. Its CAS No. 227318-75-4 serves as a unique identifier, facilitating procurement and regulatory compliance.
In conclusion, 1H-Imidazo[4,5-c][1,5]naphthyridin-4-amine, 2-methyl-1-(2-methylpropyl)- (CAS No. 227318-75-4) represents a promising compound with diverse applications in drug discovery and material science. Its structural features, combined with ongoing research into its biological activity and synthetic optimization, position it as a valuable asset in the scientific community. As interest in targeted therapies and sustainable chemistry continues to rise, this compound is likely to remain a focal point of innovation and exploration.
227318-75-4 (1H-Imidazo[4,5-c][1,5]naphthyridin-4-amine,2-methyl-1-(2-methylpropyl)-) Related Products
- 852719-43-8(1H-Imidazo[4,5-c][1,5]naphthyridin-4-amine,2-(chloromethyl)-1-(2-methylpropyl)-)
- 227318-71-0(1H-Imidazo[4,5-c][1,5]naphthyridin-4-amine, 1-(2-methylpropyl)-)
- 9050-31-1((Hydroxypropyl)methyl Cellulose Phthalate)
- 151751-58-5(1H-Imidazo[4,5-c]quinoline-1-ethanol, 4-amino-α,α,2-trimethyl-)
- 144875-29-6(1H-Imidazo[4,5-c]quinoline-2-methanol, 4-amino-1-(2-methylpropyl)-)
- 149876-20-0(1H-Imidazo[4,5-c]quinolin-4-amine, 2-ethyl-1-(2-methylpropyl)-)
- 313350-30-0(1H-Imidazo[4,5-c]quinoline-1-butanamine, 4-amino-2-ethyl-)
- 99011-02-6(Imiquimod)
- 210304-10-2(1H-Imidazo[4,5-c]quinoline-1-butanamine, 4-amino-2-methyl-)
- 748740-52-5(1H-Imidazo[4,5-c]quinolin-4-amine, 2-(chloromethyl)-1-(2-methylpropyl)-)